In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Pirfenidone is an oral antifibrotic medication primarily used for the treatment ···【more】
Release date:2026-02-04Recommended:52
The safety of pirfenidone has been evaluated in more than 1,400 subjects, of who···【more】
Release date:2026-02-04Recommended:53
Nintedanib is a multi-targeted tyrosine kinase inhibitor; it can reduce the acti···【more】
Release date:2026-02-03Recommended:52
In 2019, nintedanib became the first therapy approved by the FDA to slow the rat···【more】
Release date:2026-02-03Recommended:55
Nintedanib is a small-molecule tyrosine kinase inhibitor that binds to growth fa···【more】
Release date:2026-02-03Recommended:53
Nintedanib is indicated for the treatment of diseases that cause scarring and ha···【more】
Release date:2026-02-03Recommended:59
Elacestrant is the world’s first approved oral selective estrogen receptor degra···【more】
Release date:2026-02-02Recommended:59
Before starting elacestrant, discuss any questions or concerns with your medical···【more】
Release date:2026-02-02Recommended:63
Take elacestrant daily and always follow the guidance of your medical team stric···【more】
Release date:2026-02-02Recommended:58
Elacestrant is indicated for the treatment of postmenopausal women or adult men ···【more】
Release date:2026-02-02Recommended:65
Anagrelide is indicated to reduce the risk of blood clots in patients with throm···【more】
Release date:2026-01-30Recommended:43
Special caution is required when using anagrelide, as certain drugs may interact···【more】
Release date:2026-01-30Recommended:40